Edward Hellriegel
2Patents
1h-index
6Co-inventors
30Inventor score
Filing activity: Mar 26, 2021 → Nov 8, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11844801B2 | Oral compositions of MK2 pathway inhibitor for treatment of immune conditions | Chemistry; Metallurgy | 1 | Active |
| US12370195B2 | Oral compositions of MK2 pathway inhibitor for treatment of immune conditions | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.